Talk:Androgen replacement therapy/Diabetes and testosterone

In men over 45 are more likely, the risks of diabetes and of testosterone deficiency (in men, called hypogonadism or more specifically hypoandrogenism) are strongly correlated. Testosterone replacement therapies have been shown to improve blood glucose management. Still, "it is prudent not to start testosterone therapy in men with diabetes solely for the purpose of improving metabolic control if they show no signs and symptoms of hypogonadism."

Management guidelines for diabetes developed by expert groups in Europe and the United States are to some extent at odds with more recent Canadian consensus guidelines.